XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen ...

Fortress Biotech, Inc. ("Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to ...

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue ...

2:00 p.m. – 2:30 p.m. ET: Fireside Chat 5:00 p.m. – 6:00 p.m. ET: Panel Presentation: Development Stage Companies – Where Do Royalty and Tech Platform Plays Fit? To register for the ...

24, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing ... in a fireside chat at the virtual Lytham Partners Fall 2024 Investor ...

The company has so far built a “compelling body ... XLRP patients improve their ability to visually navigate through a virtual maze in the phase 3 Lumeos trial. Although the study did make ...

In line with this evolution, Turbine is opening its previously internal virtual lab to the ... with leading pharma and biotech companies, including Bayer, AstraZeneca, Ono, and Cancer Research ...

“We are continuously evaluating innovative approaches in drug development and have invested in virtual control ... A spokesperson told Fierce Biotech that the company does not comment on stock ...

and members of management will participate in one-on-one meetings at the BTIG Virtual Biotechnology Conference being held August 5-6, 2024. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a ...

Well, Arizona State University made it a (virtual) reality ... We then took it over and then we started a company called Dreamscape Learn. “What happens is that you're learning biology now ...